Potential effect modifiers | PM2.5 7th to 18th weeks of gestation | O3 Preconception weeks | O3 9th to 28th weeks of gestation |
---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Asthma | |||
Presence | 1.21 (1.05 – 1.35) | 0.96 (0.88 – 1.04) | 1.12 (1.07 – 1.15) |
Absence | 1.06 (1.01 – 1.10) | 1.03 (1.01 – 1.06) | 1.04 (1.01 – 1.07) |
P value for effect modification | 0.099 | 0.331 | 0.041 |
Chronic hypertension | |||
Presence | 0.95 (0.80 – 1.14) | 0.96 (0.86 – 1.08) | 1.03 (0.88 – 1.21) |
Absence | 1.07 (1.02 – 1.11) | 1.00 (0.99 – 1.02) | 1.08 (1.04 – 1.12) |
P value for effect modification | 0.754 | 0.852 | 0.842 |
NDVI | |||
1st tertile | 1.10 (1.06 – 1.14) | 1.01 (0.98 – 1.04) | 1.05 (1.02 – 1.09) |
2nd tertile | 1.07 (1.02 – 1.11) | 1.03 (1.01 – 1.06) | 1.08 (1.04 – 1.12) |
3rd tertile | 1.04 (1.00 – 1.08) | 1.00 (0.98 – 1.03) | 1.04 (1.01 – 1.06) |
P value for effect modification | 0.423 | 0.732 | 0.891 |
GVI | |||
1st tertile | 1.12 (1.07 – 1.16) | 1.00 (0.97 – 1.03) | 1.02 (0.98 – 1.06) |
2nd tertile | 1.06 (1.02 – 1.10) | 1.01 (0.98 – 1.04) | 1.06 (1.02 – 1.10) |
3rd tertile | 1.07 (1.02 – 1.11) | 1.03 (1.00 – 1.06) | 1.09 (1.04 – 1.13) |
P value for effect modification | 0.521 | 0.789 | 0.652 |
Active Living Environment | |||
1st tertile | 1.06 (1.01 – 1.10) | 1.00 (0.97 – 1.04) | 1.03 (0.99 – 1.07) |
2nd tertile | 1.02 (0.98 – 1.06) | 1.01 (0.99 – 1.04) | 1.06 (1.02 – 1.10) |
3rd tertile | 1.12 (1.08 – 1.16) | 1.03 (1.00 – 1.05) | 1.08 (1.04 – 1.12) |
P value for effect modification | 0.489 | 0.921 | 0.356 |